找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Development in Psychiatry; Matthew Macaluso,Sheldon H. Preskorn,Richard C. Sh Book 2023 The Editor(s) (if applicable) and The Author(

[復(fù)制鏈接]
查看: 16929|回復(fù): 58
樓主
發(fā)表于 2025-3-21 17:50:42 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Drug Development in Psychiatry
編輯Matthew Macaluso,Sheldon H. Preskorn,Richard C. Sh
視頻videohttp://file.papertrans.cn/284/283063/283063.mp4
概述Reviews critical elements of both basic and clinical science as they pertain to drug development in psychiatry.It covers both historical elements and modern interpretations to understand best practice
叢書名稱Advances in Neurobiology
圖書封面Titlebook: Drug Development in Psychiatry;  Matthew Macaluso,Sheldon H. Preskorn,Richard C. Sh Book 2023 The Editor(s) (if applicable) and The Author(
描述.The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology..The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:.a.?????? ?Prior to the 1960s - Drug discovery by chance observation.b.?????? The last 50 years – refined targeting of CNS drugs without the discovery of mechanistically new drugs.c.?????? The future – the discovery and development of mechanistically n
出版日期Book 2023
關(guān)鍵詞clinical trial; SPECT; APOE4; fMRI; florbetapir; biomarkers; clinical psychiatry; psychiatric medications
版次1
doihttps://doi.org/10.1007/978-3-031-21054-9
isbn_softcover978-3-031-21056-3
isbn_ebook978-3-031-21054-9Series ISSN 2190-5215 Series E-ISSN 2190-5223
issn_series 2190-5215
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Drug Development in Psychiatry影響因子(影響力)




書目名稱Drug Development in Psychiatry影響因子(影響力)學(xué)科排名




書目名稱Drug Development in Psychiatry網(wǎng)絡(luò)公開度




書目名稱Drug Development in Psychiatry網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Drug Development in Psychiatry被引頻次




書目名稱Drug Development in Psychiatry被引頻次學(xué)科排名




書目名稱Drug Development in Psychiatry年度引用




書目名稱Drug Development in Psychiatry年度引用學(xué)科排名




書目名稱Drug Development in Psychiatry讀者反饋




書目名稱Drug Development in Psychiatry讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:54:29 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:26:41 | 只看該作者
地板
發(fā)表于 2025-3-22 05:47:41 | 只看該作者
https://doi.org/10.1007/978-3-663-11765-0velopment, it is important to first understand the history of psychiatry including early attempts at drug discovery and develoment. The early history of psychiatry is mired with the use of inhumane experimental treatments and the institutionalization of patients in asylums. Some of the earliest drug
5#
發(fā)表于 2025-3-22 11:26:36 | 只看該作者
Integrationstheorie und Mehrebenenpolitik,al models have been essential in the in vivo validation of novel drug targets, establishment of lead compound pharmacokinetic to pharmacodynamic relationships, optimization of lead compounds through preclinical candidate selection, and development of translational measures of target occupancy and fu
6#
發(fā)表于 2025-3-22 16:34:47 | 只看該作者
Grundkonzepte der Programmierung and neurodegenerative disorders such as depression, ADHD, neuropathic pain, anxiety disorders, stimulant use disorders, epilepsy, and Parkinson’s disease. The MAT family is comprised of three main members – the dopamine transporter (DAT), the norepinephrine transporter (NET), and the serotonin tran
7#
發(fā)表于 2025-3-22 18:55:46 | 只看該作者
8#
發(fā)表于 2025-3-22 22:17:18 | 只看該作者
Grundkonzepte der Programmierunghic and comorbid clinical characteristics. Is this medicine more effective, safe, tolerable, or affordable than the options used in the past? A payer may ask if the new medication offers a more effective, cost-efficient, or convenient alternative to those treatments already being covered. These are
9#
發(fā)表于 2025-3-23 03:53:59 | 只看該作者
Objektorientierte Programmierungrom investments diverted to other therapeutic areas to reduced reliance on efficacy claims derived from preclinical models. In this chapter, we argue that there are several existing examples that teach us on what needs to be done to improve the success rate. We advocate the reverse engineering appro
10#
發(fā)表于 2025-3-23 07:23:27 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 17:48
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
漳州市| 长武县| 玉树县| 南宫市| 安福县| 灵寿县| 广西| 搜索| 宝坻区| 辽阳市| 新邵县| 新泰市| 五大连池市| 光山县| 濮阳县| 黑龙江省| 久治县| 广东省| 庐江县| 元阳县| 水城县| 曲周县| 仙桃市| 饶阳县| 长岭县| 合山市| 长治县| 绿春县| 玉田县| 汪清县| 万全县| 应用必备| 漳州市| 十堰市| 贡嘎县| 漠河县| 靖江市| 常山县| 江西省| 莒南县| 新干县|